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Abstract: Heparin (H) and heparan sulfate (HS) are polysaccharides belonging to the glycosaminoglycan (GAG) family. As a proteoglycan, HS is present either in the outer face of the cell membrane or in the extra cellular matrix (ECM). HS is involved in the modulation of the communication between cells and cell-ECM. Like polyanionic molecules, H/HS are involved in a great number of GAG-protein interactions and biological activities such as blood coagulation, lipid metabolism, cell adhesion and growth factor regulation (Ori, A., 2008; Capila, I., 2002). Recently, it has been shown an increasing in H/HS-protein complexes structural studies. This lead to an improved understanding of H/HS-protein interactions. Does H/HS interaction network represent the crossroad of the cell-ECM molecular net? The aim of the present study is oriented to clarify some H/HS network aspects, for instance the H/HS-fibroblast growth factor (FGF) family interactions, the H/HS-βamyloid (βA) and the H/HS-antithrombin III (AT) interactions. Different methods were applied to elucidate biochemical and structural data: Nuclear Magnetic Resonance (NMR), Dynamic Light Scattering (DLS) and Surface Plasmon Resonance (SPR). Literature results showed as oligosaccharides derived from H (H oligosaccharides) are able to mimic H/HS effects in H/HS-protein binding and biological activity (Linhardt, R. J., 1999; Yates, E. A., 2004; Guerrini M., 2002). According to H oligosaccharides properties, we decide to use H oligosaccharides having different sulfation pattern and derived by partial depolimerization of beef lung and pig mucosal heparin. NMR and DLS data confirm the great importance of βA folding for the chemo-physical environment as previously reported (Zagorski M. G., 1992; Mandal P. K., 2004; Valerio M., 2008). Preliminary NMR results of βAs (βA (1-40), βA (1-28) and βA (25-35))/H oligosaccharides in solution suggest a critical role in βAs stability. 1H-15N heteronuclear correlation spectroscopy (HSQC) spectra acquired before and after H tetrasaccharide and AGA*IA (see methods) addition show some interesting differences, showing the influence of sulfation and length of the chains in the aggregation phenomena. SPR results confirm the importance of sulfation pattern and monosaccharides sequence in FGF/H oligosaccharides interactions. Changing in sulfation pattern (6-O desulfation or 2-O desulfation) strongly affects FGF-1/H oligosaccharides-binding mechanisms.

Materials and methods:
Materials. Recombinant human βAs (βA (1-40), βA (1-28) and βA (25-35)) were purchased from rPeptide (Bogart, GA). Recombinant human FGF-1 was directly purified from E.coli in the laboratory of Prof. D. G. Fernig (Liverpool, UK). Heparin was a pig intestinal preparation provided by Prof. D. G. Fernig (Liverpool, UK). Heparin oligosaccharides belong to Ronzoni Institute GAG library:









G6386	Beef Lung	octa/decasaccharide (mixture)	2-O desulfated

AGA*IA is heparin pentasaccharide antithrombin III (AT) binding site. A synthetic version of AGA*IA was purchased from GlaxoSmithKline (ARIXTRA). Heparin as starting material was commercial beef lung heparin provided by Sanofi-Aventis. Biotinylated pig mucosa H and free soluble pig mucosa H was provided by Dr. E. A. Yates (Liverpool, UK). Deuterated hexafluoroisopropanol (dHFIP) was purchased from CortecNet (Paris, France).

NMR experiments. βA (1-40) and βA (1-28) and were dissolved in phosphate buffer (PB) 20 mM ([βA (1-40)]=1,15 mM; [βA (1-28)]=1,53 mM). βA (25-35) has been dissolved in 20% deuterated HFIP ([βA (25-35)]=1 mM). 1H, total correlation spectroscopy (TOCSY), nuclear Overhauser Effect Spectroscopy (NOESY) and HSQC spectra for the three differents βAs were relatively recorded at 5 °C, 7 °C and 27 °C at different pH values. Heparin oligosaccharides used to study βA (1-40)/H oligosaccharides complex and βA (1-28)/H oligosaccharides complex were dissolved in PB 20 mM (AGA*IA and G5932g). Heparin oligosaccharides used to study βA (25-35)/H oligosaccharides complex were dissolved in 20% dHFIP (G5932g; pH 3.6). All differents samples were prepared in final volume of 220 μl. All monodimensional H (1H), TOCSY, NOESY and HSQC spectra were recorded at 600 Mhz on a Bruker Avance 600 spectrometer, equipped with a 5 mm cryoprobe.

Dynamic Light Scattering (DLS). βA (1-40) preparation: aliquots of 20 μg has been dissolved in 10 mM NaOH. After 1' mixing, big aggregate were broken by sonication (1'). Sonicated samples were diluted in 0,1 M PB to a final amyloid concentration of 0,23 mM. Before analysis final sample were mixed and sonicated (1'). In order to eliminate all the remaining big order aggregates, samples were filtered with centricon membrane (Ultracel YM-10, cut-off 10 KDalton). Heparin oligosaccharides were dissolved in the same PB. DLS conditions: T=20 °C, run duration 4'' and experiments number 30.

Surface Plasmon Resonance (SPR). Measurements were performed with a streptavidin functionalized surfare provided by K. A. Uniewicz (Liverpool, UK). SPR is an optical approach based on refractive index (n) changing meausurement. Light source is provided by continuum laser. Laser scans from the bottom of the surface (no n changing, n1) until the end of surface's cuvette (n changing in case of binding, n2). Differences between n2 and n1 are expressed in arcsecond (RU). The functionalized surface was incubated with biotinylated H (probe) followed by PBST (PB 5 mM, NaCl 140 mM and 0,02 % Tween20) wash to remove not bind probe. When ligand is not bind to the probe the system measures ~0 RU. A single binding assay consisted of adding the FGF-1 at a known concentration (14 μg/ml) in 5 μl of PBST to a cuvette containing 45 μl of PBST. The association reaction was followed over a set time, usually 210 s. The cuvette was then washed five times with 50 μl of PBST and the dissociation of bound ligate into the bulk PBST was followed over time. The surface was regenerated by washing three times with 50 μl of NaCl 2 M, Na2HPO4 10 mM, pH 7.2. Binding parameters were calculated from the association phase of the binding reactions using the non-linear curve fitting FastFit. Competitive binding: all the competitors (not biotinylated pig mucosa, G6375, G6379, G6377, G6385, G6384, G6394 and G6386) were prepared in PBST at different concentrations (0 μg/ml, 10 μg/ml, 100 μg/ml, 1 mg/ml and 2 mg/ml). A single competitive binding assay was like single binding assay, but instead of 45 μl of PBST the cuvette contained 40 μl of PBST and the remaining volume was substituted with 5 μl of competitor solution. Association, dissociation, regeneration were done in the same conditions of single binding assay. Binding parameters were calculated as for single binding assay. All the experiments were done in a iAsys auto + advantage (NeoSensors, County Durham, UK). Analysis software was provided by the manufacturer.

Results: 
DLS βA (1-40) aggregation studies: DLS allows to follow the dimension growth of the species in solution. The machine measures the intensity of scattered light. After data elaboration, this technique allows to calculate the hydrodynamic radius (Rh) and the percentage of the different species. We decided to follow the monomer species percentage like the aggregation marker. βA (1-40), in our experimental conditions, shows about 30% of monomer at aggregation kinetics initial time. We made parallels aggregation study of βA (1-40) in the presence of AGA*IA (molar ratio 1:5) and G5932g (molar ratio 1:5). Aggregation studies were done for 8h. Preliminary data showed 8% of monomer after 8h. The aggregation seems to be slower in the presence of AGA*IA (monomer % after 8h, 30%), while in the presence of G5932g the aggregation is intermediate between the control and in the presence of AGA*IA (monomer % after 8h, 15%). Aggregation studies with others βAs peptides (βA (1-28) and βA (25-35)) and others oligosaccharides are still in progress.

NMR studies on βA: The 1H spectra of βAs showed some differences in profiles due to changing in chemo-physical environment (acidic Vs basic pH condition) and it also showed stability of the sample 24 h after preparation. We performed a titration of βA (1-40) with AGA*IA, in the following molar ratios; 2:1, 1:1 and 1:2. The titration showed no change in chemical shift positions, but a change in attenuation of the signals intensity was observed. This may be due to the precipitation of the peptide/AGA*IA insoluble aggregate (the solution became turbid) or to some change in protein stability (unfolding phenomena). In order to understand which kind of phenomena were involved during βA-oligosaccharide interactions, we applied the same approach on a simpler beta-amyloid peptide, βA (1-28), similarly to the βA (1-40). The titration didn't show any change in chemical shift position, but an attenuation in the signals intensity related to the amount of oligosaccharide was observed. We decided to use another amyloid peptide, as previously explained, βA (25-35), an 11 amino acid peptide, from the C-terminus of the βA (1-40). As described in the literature (D'Ursi, A. M., 2004; Pike C. J., 1995), this peptide retains comparable βA (1-40) neurotoxicity, but it shows a slower aggregation rate. The preliminary study was carried out with 20% of HexaFluoroIsoPropanol (HFIP) to emulate the lipophilic cellular membrane environment, by 1D and 2D-correlation spectroscopy. We had problem to acquire the spectra of βA (25-35)/G5932g complex (no signals after G5932g addition (2:1 molar ratio). The optimization of the experimental conditions is still in progress. 

Future plans (βAs/H complex): 
Repeat the DLS experiments also for the others two βA and to obtain a better solubilization approach to get a good monomer %. This will allow us to better follow aggregation kinetics and to increase the resolution of NMR spectra. The future NMR experiments will be focus on clarification of the structures modification caused by H oligosaccharides presence (with or without the standard sulfation pattern). 

H oligosaccharides and FGF-1 interaction studies: The affinities of structurally homogeneous oligosaccharides obtained by beef-lung heparin, (G6375, G6379, G6377, G6385, G6384, G6394 and G6386) for FGF-1 were evaluated by their ability to displace the protein from an iAsys surface to which a pig mucosa H was covalently bound through biotinylation. It was possible to get the Ic50 (the concentration of a competitor that is required for 50% binding inhibition) just for fully sulfated H decasaccharide (G6377) The regular heparin sequence (2-O sulfated-IdoA - N,6-disulfated glucosamine), together with an appropriate chain length (not less than octasaccharide) are necessary for the binding inhibition. The same panel of experiments for FGF-2 is still in progress.

Future plans (FGFs/H complex): 
As previously said, we want to better study interaction mechanisms between H and FGF family. We will first repeat the same experimental panel with FGF-2. This will be followed by structural studies to identify at the molecular level the interaction mechanism.

